AstraZeneca

Company Information

Address:

Level 9 2 Kingdom Street
London
W2 6BD

Tel:

+44 (0)20 7604 8000

Fax:

+44 (0)20 7604 8270

E-Mail:

IR@astrazeneca.com

Secretary:

Adrian Kemp

Registrar:

Company Overview

AstraZeneca is one of only a handful of pure-play biopharmaceutical companies to span the entire value chain of a medicine from discovery, early- and late-stage development to manufacturing and distribution, and the global commercialisation of primary care, specialty care-led and specialty care medicines that transform lives

Annual Reports

Description Report Date Published
Annual Report 201431-12-201405-02-2015
Annual Report 201331-12-201306-02-2014
Annual Report 201231-12-201231-01-2013
Annual Report 201131-12-201102-02-2012
Annual Report 201031-12-201027-01-2011
Annual Report 200931-12-200928-01-2010
Annual Report 200831-12-200829-01-2009
Annual Report 200731-12-200731-01-2008

Interim Reports

Description Report Date Published
Interim Report 201430-06-201431-07-2014
Interim Report 201330-06-201301-08-2013
Interim Report 201230-06-201226-07-2012

Dividend Histroy

Type Dividend Payment Date
Interim53.100015-09-2014
Interim116.800024-03-2014
Interim59.200016-09-2013
Interim120.500018-03-2013
Interim58.100010-09-2012
Interim123.600019-03-2012
Interim51.900012-09-2011
Interim116.700014-03-2011
Interim44.900013-09-2010
Interim105.400015-03-2010
Interim27.800014-09-2009
Interim0.590014-09-2009
Interim36.000014-09-2009
Interim104.800016-03-2009
Interim27.800015-09-2008
Interim67.700017-03-2008
Interim25.300017-09-2007
Interim63.000019-03-2007
Interim26.600018-09-2006
Interim51.800020-03-2006
Interim21.900019-09-2005
Interim34.300021-03-2005
Interim16.000020-09-2004
Interim29.400006-04-2004
Interim15.900006-10-2003
Interim28.500007-04-2003
Interim14.700007-10-2002
Interim33.200008-04-2002
Interim16.100005-10-2001
Interim32.100009-04-2001
Interim15.300023-10-2000
Interim29.100017-04-2000
Interim14.200025-10-1999
A B C D E F G
H I J K L M
N O P Q R S T
U V W X Y Z #